MYOCARDIAL PERFUSION IMAGING METHODS AND COMPOSITIONS
    1.
    发明申请
    MYOCARDIAL PERFUSION IMAGING METHODS AND COMPOSITIONS 有权
    心肌灌注成像方法和组成

    公开(公告)号:US20100183503A1

    公开(公告)日:2010-07-22

    申请号:US12749328

    申请日:2010-03-29

    IPC分类号: A61K51/00 A61K49/00

    CPC分类号: A61K31/7076 A61K2300/00

    摘要: A myocardial imaging method that is accomplished by administering one or more adenosine A2A adenosine receptor agonist to a human undergoing myocardial imaging as well as pharmaceutical compositions comprising at least one A2a receptor agonist, at least one liquid carrier, and at least one co-solvent.

    摘要翻译: 通过向经历心肌成像的人施用一种或多种腺苷A2A腺苷受体激动剂以及包含至少一种A2a受体激动剂,至少一种液体载体和至少一种助溶剂的药物组合物来实现的心肌成像方法。

    Myocardial perfusion imaging methods and compositions
    2.
    发明申请
    Myocardial perfusion imaging methods and compositions 审中-公开
    心肌灌注成像方法和组成

    公开(公告)号:US20050020915A1

    公开(公告)日:2005-01-27

    申请号:US10766403

    申请日:2004-01-27

    CPC分类号: A61K31/7076 A61K2300/00

    摘要: A myocardial imaging method that is accomplished by administering one or more adenosine A2A adenosine receptor agonist to a human undergoing myocardial imaging as well as pharmaceutical compositions comprising at least one A2a receptor agonist, at least one liquid carrier, and at least one co-solvent.

    摘要翻译: 通过向经历心肌成像的人施用一种或多种腺苷A2A腺苷受体激动剂以及包含至少一种A2a受体激动剂,至少一种液体载体和至少一种助溶剂的药物组合物来实现的心肌成像方法。

    Myocardial perfusion imaging methods and compositions
    5.
    发明授权
    Myocardial perfusion imaging methods and compositions 有权
    心肌灌注成像方法和组成

    公开(公告)号:US08133879B2

    公开(公告)日:2012-03-13

    申请号:US12749328

    申请日:2010-03-29

    IPC分类号: A61K31/70

    CPC分类号: A61K31/7076 A61K2300/00

    摘要: The present disclosure provides 2-adenosine N-pyrazole compounds of structural formula shown below that are potent and selective agonists for A2A adenosine receptor, compositions comprising these compounds, and methods for using these compounds in a variety of applications including myocardial perfusion imaging methods.

    摘要翻译: 本公开提供了下列结构式的2-腺苷N-吡唑化合物,其为A2A腺苷受体的有效和选择性激动剂,包含这些化合物的组合物,以及在各种应用中使用这些化合物的方法,包括心肌灌注成像方法。